Your browser doesn't support javascript.
loading
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.
Rugo, H S; Pritchard, K I; Gnant, M; Noguchi, S; Piccart, M; Hortobagyi, G; Baselga, J; Perez, A; Geberth, M; Csoszi, T; Chouinard, E; Srimuninnimit, V; Puttawibul, P; Eakle, J; Feng, W; Bauly, H; El-Hashimy, M; Taran, T; Burris, H A.
Afiliação
  • Rugo HS; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA. Electronic address: hrugo@medicine.ucsf.edu.
  • Pritchard KI; Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada.
  • Gnant M; Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Noguchi S; Department of Breast and Endocrine Surgery, Osaka University, Osaka, Japan.
  • Piccart M; Institut Jules Bordet, Brussels, Belgium.
  • Hortobagyi G; The University of Texas MD Anderson Cancer Center, Houston.
  • Baselga J; Memorial Sloan-Kettering Cancer Center, New York.
  • Perez A; Memorial Cancer Institute, Hollywood, USA.
  • Geberth M; Praxisklinic am Rosengarten Mannheim, Schwerpunktpraxis für Gynaekologische Onkologie, Mannheim, Germany.
  • Csoszi T; Department of Medical Oncology, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Hungary.
  • Chouinard E; Cambridge Memorial Hospital, Cambridge, Canada.
  • Srimuninnimit V; Siriraj Hospital, Mahidol University, Bangkok.
  • Puttawibul P; Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand.
  • Eakle J; Florida Cancer Specialists, Ft Myers.
  • Feng W; Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Bauly H; Novartis Pharma AG, Basel, Switzerland.
  • El-Hashimy M; Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Taran T; Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Burris HA; Sarah Cannon Research Institute, Nashville, USA.
Ann Oncol ; 25(4): 808-815, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24615500
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sirolimo / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Clinical_trials / Incidence_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sirolimo / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Clinical_trials / Incidence_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido